PoliticalRepoPoliticalRepo

United States · Bill · S

S. 97 (116th)

Affordable and Safe Prescription Drug Importation Act

referredUnited States· United States Congress· EN

Introduced

10 January 2019

Last action

10 January 2019 · Introduced

Status

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

Bernie Sanders, Sen. Booker, Cory A. [D-NJ], Sen. Casey, Robert P., Jr. [D-PA], Tammy Baldwin, Richard Blumenthal, Sen. Brown, Sherrod [D-OH], Maria Cantwell, Kirsten Gillibrand, Sen. Harris, Kamala D. [D-CA], Maggie Hassan, Martin Heinrich, Angus King, Sen. Leahy, Patrick J. [D-VT], Amy Klobuchar, Sen. Manchin, Joe, III [I-WV], Jeff Merkley, John Reed, Jeanne Shaheen, Tina Smith, Sen. Stabenow, Debbie [D-MI], Sen. Udall, Tom [D-NM], Chris Van Hollen, Elizabeth Warren, Sheldon Whitehouse, Ron Wyden

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Summary

Affordable and Safe Prescription Drug Importation Act This bill addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 10 January 2019

    Introduced

    Introduced in Senate

    Source: IntroReferral

  2. 10 January 2019

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.